Subject Expert Committee (SEC) meets to consider Emergency Use Authorisation request from Pfizer, SII and Bharat Biotech
The Subject Expert Committee (SEC) in the Central Drugs Standard Control Organisation (CDSCO) to consider the Emergency Use Authorisation (EUA) request of